A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00927498 |
Recruitment Status :
Completed
First Posted : June 25, 2009
Last Update Posted : July 11, 2013
|
Sponsor:
Acute Leukemia French Association
Collaborator:
Versailles Hospital
Information provided by (Responsible Party):
Acute Leukemia French Association
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | July 2011 |
Actual Study Completion Date : | July 2013 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):